Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
253.4 GBX | -0.47% | -2.23% | +4.10% |
May. 17 | Goldman Sachs Trims Convatec Group PT, Keeps Rating at Buy | MT |
May. 17 | Jefferies says buy Tritax Big Box post merger | AN |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With an expected P/E ratio at 26.81 and 20.81 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 2.78 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.10% | 6.62B | B+ | ||
-5.43% | 181B | C+ | ||
+4.30% | 114B | C | ||
-3.09% | 68.29B | A | ||
+5.86% | 52.24B | B- | ||
+8.15% | 44.3B | B- | ||
+6.67% | 42.73B | B+ | ||
+25.54% | 32.52B | B | ||
+20.03% | 26.02B | A- | ||
+1.00% | 25.91B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CTEC Stock
- Ratings ConvaTec Group Plc